How to develop innovations that people buy?
This is a question that’s on every Managing Director’s mind. Consider this: European Fortune 500 companies invest well over 100B€ in innovation a year. And, yet 70 to 90% of innovations fail.
Guillaume is helping Fortune 500 accounts in their digital transformation.
Guillaume is helping Fortune 500 accounts succeed at innovation, by developing a novel approach to creating innovations that people buy. He’s working with multiple global companies on innovation issues, including Orange, Pfizer, Merck, Danone, Air Liquide, Vodafone, Microsoft and Schneider.
He has helped Inova, an innovation software company, improve its product portfolio by applying the “Jobs-to-be done” innovation approach, resulting in new client acquisitions.
He has worked with a Paris-based consultancy focused on healthcare, to create an office in the NYC/Princeton area. There, he helped leading Pharmaceutical companies, including Pfizer and Merck move from a molecule-based business model to a solutions business model. He has sold the largest innovation consulting project in healthcare Alcimed ever sold in its 17 year old history.
He has helped leading software companies, such as Microsoft and Dassault Systèmes, with their innovation capabilities.
Guillaume has received his Master’s Degree in Philosophy at Sorbonne University in Paris and his MBA (“Diplôme Grande Ecole”) from ESSEC, a leading business school based out of Paris. A Virginian by birth and Frenchmen by education, Guillaume takes part in the transatlantic dialog on innovation.